Author

J. Tepe

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Al-Janadi· 1 shared A. R. Marcadis· 1 shared A. R. Shaha· 1 shared A. S. Ho· 1 shared A. Vanecek· 1 shared B. R. Untch· 1 shared B. Xu· 1 shared C. E. Swartzwelder· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Al-Janadi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Enhancing c-MYC degradation via 20S proteasome activation induces in vivo anti-tumor efficacy

E. Njomen, T. Lansdell, A. Vanecek, V. Benham, M. Bernard, Y.-T. Yang, P. Schall, D. Isaac, O. Alkharabsheh, A. Al-Janadi, m. Giletto, E. Elsworth, C. Taylor, T. Yang, m. Bailie, , J. Tepe

This study shows that activating the 20S proteasome with small molecules reduces c-MYC-driven cancer growth in vitro and in vivo, including in bortezomib-resistant cells.

bioRxiv · Aug 24, 2020 · PreprintPharmacology & Toxicology

Inter-institutional variation in predictive value of the ThyroSeq v2 genomic classifier for cytologically indeterminate thyroid nodules

A. R. Marcadis, P. Valderrabano, A. S. Ho, J. Tepe, C. E. Swartzwelder, S. Byrd, W. L. Sacks, B. R. Untch, A. R. Shaha, B. Xu, O. Lin, R. A. Ghossein, R. J. Wong, J. L. Marti, L. G. T. Morris

This study evaluates the predictive value of ThyroSeq v2 across four institutions for indeterminate thyroid nodules, finding variable positive predictive values and differences in malignancy risk assessment.

bioRxiv · Apr 22, 2018Cancer Biology